NIH-funded research U01 cooperative agreement

How eczema (atopic dermatitis) progresses in children

Official title: Atopic dermatitis: mechanisms of disease progression

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11307661 · Data updated 2026-11-12

This project follows children with eczema to find patterns in their skin, gut, airways, and blood that predict who may develop allergies or asthma.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startApril 20, 2020
Project endMarch 31, 2027
Funding year2026
Award (this year)$224,999
NIH project number5U01AI152034-07
Project IDNIH-11307661 on NIH RePORTER

Who could benefit from this research

Could help

Young children (infants through pre-teens) diagnosed with atopic dermatitis/eczema, especially those with early-onset disease, are the ideal participants.

Less likely to help

Adults, people without eczema, or participants seeking immediate changes to their treatment are unlikely to receive direct therapeutic benefit from this observational cohort.

What this research studies

If my child joins, clinicians will follow them over time with regular clinic visits and sample collection. They will collect skin, stool, airway and blood samples and use many lab tests and measurements to group children by shared symptoms and biology. The team uses these groups to look for early signs that predict whether a child will go on to develop food allergies, allergic rhinitis, or asthma. The study is focused on young children and emphasizes detailed, repeated measurements rather than testing a treatment.

Why it matters

Potential benefit: If successful, this work could help doctors predict which children with eczema are most likely to develop other allergic conditions and guide earlier prevention or personalized care.

How similar studies have gone: This builds on prior atopic march and cohort research but is relatively novel as the first U.S. early-life mechanistic cohort using multiple biological measures to define subgroups and predict outcomes.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Khurana Hershey, Gurjit K. — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Khurana Hershey, Gurjit K.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.